Multiple lawsuits have since been filed across the U.S., alleging that Pfizer knew or shouldve known about the link between this medication and brain tumors
Health Canada says it is currently reviewing eight additional generic semaglutide submissions following its April 28, 2026 authorization of a generic semaglutide injection filed by Dr
Closing: The Clinical Bottom Line on BPC-157 Benefits BPC-157 works best when it is used for the right indication, at the right time in the recovery process, with the right source compound
Advocates like James Lin, a geriatric-medicine specialist and president of the LECOM Institute for Successful Living in Erie, Pa., told the committee that MOTS-C helps address aging by improving key metrics like grip strength, metabolic function and bone loss, a sentiment echoed by several other speakers
A responsible program starts with blood work
Studies have demonstrated that transitioning between GLP-1 receptor agonists is generally well-tolerated when conducted appropriately, with patients able to maintain therapeutic benefits throughout the transition process